pubmed.ncbi.nlm.nih.gov

Increasing cAMP attenuates activation of mitogen-activated protein kinase - PubMed

️Fri Jan 01 1993

Increasing cAMP attenuates activation of mitogen-activated protein kinase

B R Sevetson et al. Proc Natl Acad Sci U S A. 1993.

Abstract

Activation of the mitogen-activated protein kinase (MAP kinase) isoforms ERK1 and ERK2 was investigated in rat adipocytes. Kinase activities were measured by using myelin basic protein as substrate after the isoforms were resolved by Mono Q chromatography or by immunoprecipitation with specific antibodies. Insulin increased the activity of both isoforms by 3- to 4-fold. The beta-adrenergic agonist isoproterenol was without effect in the absence of insulin but markedly reduced the increases in ERK1 and ERK2 activities produced by the hormone. MAP kinase activation was also attenuated by forskolin and glucagon, which increase intracellular cAMP, and by dibutyryl-cAMP, 8-bromo-cAMP, and 8-(4-chlorophenylthio)-cAMP. Thus, increasing cAMP is associated with decreased activation of MAP kinase by insulin. Forskolin also inhibited activation of MAP kinase by several agents (epidermal growth factor, phorbol 12-myristate 13-acetate, and okadaic acid) that act independently of insulin receptors. Moreover, forskolin did not inhibit insulin-stimulated tyrosine phosphorylation of the insulin receptor substrate IRS-1. Therefore, the inhibitory effect on MAP kinase did not result from compromised functioning of the insulin receptor. The inhibitory effect was not confined to adipocytes, as forskolin and dibutyryl-cAMP inhibited the increase in MAP kinase activity by phorbol 12-myristate 13-acetate in wild-type CHO cells. In contrast, these agents did not inhibit MAP kinase activity in mutant CHO cells (line 10248) that express a cAMP-dependent protein kinase resistant to activation by cAMP. Our results suggest that activation of cAMP-dependent protein kinase represents a general counter-regulatory mechanism for opposing MAP kinase activation.

PubMed Disclaimer

Cited by

RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A.
Neumann M, Grieshammer T, Chuvpilo S, Kneitz B, Lohoff M, Schimpl A, Franza BR Jr, Serfling E. Neumann M, et al. EMBO J. 1995 May 1;14(9):1991-2004. doi: 10.1002/j.1460-2075.1995.tb07191.x. EMBO J. 1995. PMID: 7744006 Free PMC article.
Integrin-associated protein stimulates alpha2beta1-dependent chemotaxis via Gi-mediated inhibition of adenylate cyclase and extracellular-regulated kinases.
Wang XQ, Lindberg FP, Frazier WA. Wang XQ, et al. J Cell Biol. 1999 Oct 18;147(2):389-400. doi: 10.1083/jcb.147.2.389. J Cell Biol. 1999. PMID: 10525543 Free PMC article.
cAMP-dependent phosphorylation and hexamethylene-bis-acetamide induced dephosphorylation of p19 in murine erythroleukemia cells.
Scheele JS. Scheele JS. Mol Cell Biochem. 1998 Aug;185(1-2):55-63. doi: 10.1023/a:1016563720515. Mol Cell Biochem. 1998. PMID: 9746212
Mutation of tyrosine-141 inhibits insulin-promoted tyrosine phosphorylation and increased responsiveness of the human beta 2-adrenergic receptor.
Valiquette M, Parent S, Loisel TP, Bouvier M. Valiquette M, et al. EMBO J. 1995 Nov 15;14(22):5542-9. doi: 10.1002/j.1460-2075.1995.tb00241.x. EMBO J. 1995. PMID: 8521811 Free PMC article.
Endogenously opsonized particles divert prostanoid action from lethal to protective in models of experimental endotoxemia.
Eierman DF, Yagami M, Erme SM, Minchey SR, Harmon PA, Pratt KJ, Janoff AS. Eierman DF, et al. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2815-9. doi: 10.1073/pnas.92.7.2815. Proc Natl Acad Sci U S A. 1995. PMID: 7708730 Free PMC article.

References

1. Cell. 1992 Mar 20;68(6):1031-40 - PubMed
1. J Biol Chem. 1964 Feb;239:375-80 - PubMed
1. J Biol Chem. 1968 Apr 25;243(8):1705-12 - PubMed
1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
1. J Biol Chem. 1971 Oct 25;246(20):6210-6 - PubMed

Increasing cAMP attenuates activation of mitogen-activated protein kinase - PubMed